These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 33661858)
1. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns. Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858 [TBL] [Abstract][Full Text] [Related]
2. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma. Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313 [TBL] [Abstract][Full Text] [Related]
3. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis. Yang K; Wu Y BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049 [TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix. Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699 [No Abstract] [Full Text] [Related]
5. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. Yang Y; Wang M; Liu B J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601 [TBL] [Abstract][Full Text] [Related]
6. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation. Wang X; Wang X; Li X; Chang Y J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674 [TBL] [Abstract][Full Text] [Related]
7. Multiple mutations of lung squamous cell carcinoma shared common mechanisms. Li Q; Hou J; Hu Z; Gu B; Shi Y Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas. Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database. Ke D; Guo Q; Fan TY; Xiao X Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657 [No Abstract] [Full Text] [Related]
10. Role of downregulated ADARB1 in lung squamous cell carcinoma. Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472 [TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma. Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870 [TBL] [Abstract][Full Text] [Related]
12. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma. Huang G; Zhang J; Gong L; Huang Y; Liu D BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809 [TBL] [Abstract][Full Text] [Related]
13. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR. Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946 [TBL] [Abstract][Full Text] [Related]
14. An integrative investigation on significant mutations and their down-stream pathways in lung squamous cell carcinoma reveals CUL3/KEAP1/NRF2 relevant subtypes. Liu Z; Deng M; Wu L; Zhang S Mol Med; 2020 May; 26(1):48. PubMed ID: 32434476 [TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma. Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209 [TBL] [Abstract][Full Text] [Related]
16. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles. Wang W; Wang S; Chu X; Liu H; Xiang M J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242 [TBL] [Abstract][Full Text] [Related]
17. A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis. Hata A; Nakajima T; Matsusaka K; Fukuyo M; Morimoto J; Yamamoto T; Sakairi Y; Rahmutulla B; Ota S; Wada H; Suzuki H; Matsubara H; Yoshino I; Kaneda A Int J Cancer; 2020 Jan; 146(2):388-399. PubMed ID: 31241180 [TBL] [Abstract][Full Text] [Related]
18. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis. Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443 [TBL] [Abstract][Full Text] [Related]
19. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma. Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578 [TBL] [Abstract][Full Text] [Related]
20. A prognostic risk model based on DNA methylation levels of genes and lncRNAs in lung squamous cell carcinoma. Wang W; Xiang M; Liu H; Chu X; Sun Z; Feng L PeerJ; 2022; 10():e13057. PubMed ID: 35356464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]